Dyslipidaemia was assessed in two ways: (1) by identifying individuals with lipid values above those recommended by scientific societies for the general population (low or moderate risk) and (2) by identifying individuals with lipid values above the P90, except for HDL-C and apoA1, where values below P10 were considered. Here, APOA1 is linked to inherited lipid metabolism disorder.